{
  "2'-F-CTP": {
    "zh": "2'-F-CTP"
  },
  "2'-F-UTP": {
    "zh": "2'-F-UTP"
  },
  "2'-OMe-ATP": {
    "zh": "2'-OMe-ATP"
  },
  "2'-OMe-UTP": {
    "zh": "2'-OMe-UTP"
  },
  "2'-acetal levulinic ester (ALE) phosphoramidite": {
    "zh": "2'-缩醛乙酰丙酸酯（ALE）亚磷酰胺"
  },
  "32P-end-labeling": {
    "zh": "32P末端标记"
  },
  "500 Å pore": {
    "zh": "500 Å孔径"
  },
  "AGT": {
    "zh": "AGT"
  },
  "AJIPHASE®": {
    "zh": "AJIPHASE®"
  },
  "ANGPTL3": {
    "zh": "ANGPTL3"
  },
  "AOF formulation": {
    "zh": "无动物及人源成分（AOF）配方"
  },
  "API sameness": {
    "zh": "API同一性"
  },
  "APOC3": {
    "zh": "APOC3"
  },
  "ASCVD": {
    "zh": "动脉粥样硬化性心血管疾病"
  },
  "ASGPR": {
    "zh": "去唾液酸糖蛋白受体"
  },
  "ASMF": {
    "zh": "ASMF备案"
  },
  "Adaptive Laboratory Evolution": {
    "zh": "适应性实验室进化"
  },
  "Ajinomoto Bio-Pharma Services": {
    "zh": "味之素生物制药服务"
  },
  "Ajinomoto OmniChem": {
    "zh": "Ajinomoto OmniChem"
  },
  "Amide linker": {
    "zh": "酰胺接头"
  },
  "Angiotensinogen": {
    "zh": "血管紧张素原"
  },
  "Antibody-Drug Conjugate": {
    "zh": "抗体偶联药物"
  },
  "BD value": {
    "zh": "BD交易价值"
  },
  "BIOSECURE Act": {
    "zh": "《生物安全法案》"
  },
  "BTT activation": {
    "zh": "BTT活化"
  },
  "Bachem": {
    "zh": "Bachem"
  },
  "BeBetter Med": {
    "zh": "必贝特"
  },
  "Beyotime": {
    "zh": "碧云天"
  },
  "Biologics License Application": {
    "zh": "生物制品上市许可申请"
  },
  "Biomaide": {
    "zh": "博迈德"
  },
  "BirA/AviTag": {
    "zh": "BirA/AviTag"
  },
  "Bis-RNAi": {
    "zh": "Bis-RNAi"
  },
  "C5": {
    "zh": "C5"
  },
  "CDE": {
    "zh": "药品审评中心"
  },
  "CDMO": {
    "zh": "合同开发与生产组织"
  },
  "CID fragmentation": {
    "zh": "碰撞诱导解离（CID）碎裂"
  },
  "CLEA-LentiKats lipase formulation": {
    "zh": "CLEA-LentiKats脂肪酶制剂"
  },
  "CMC development timeline": {
    "zh": "CMC开发周期"
  },
  "CPG support": {
    "zh": "CPG载体"
  },
  "CTA": {
    "zh": "临床试验申请"
  },
  "Calantha™": {
    "zh": "Calantha™"
  },
  "Calf Intestinal Alkaline Phosphatase": {
    "zh": "小牛肠碱性磷酸酶"
  },
  "Candida antarctica lipase B": {
    "zh": "南极假丝酵母脂肪酶B"
  },
  "Category I": {
    "zh": "第I类"
  },
  "Category II": {
    "zh": "第II类"
  },
  "Category III": {
    "zh": "第III类"
  },
  "Category IV": {
    "zh": "第IV类"
  },
  "ChemGenes": {
    "zh": "ChemGenes"
  },
  "Chinese IND": {
    "zh": "中国IND"
  },
  "Class 3": {
    "zh": "第3类"
  },
  "Complement Factor B": {
    "zh": "补体因子B"
  },
  "Complete Response Letter": {
    "zh": "完全答复函"
  },
  "Controlled pore glass": {
    "zh": "受控孔径玻璃"
  },
  "Cross-Linked Enzyme Aggregates": {
    "zh": "交联酶聚集体"
  },
  "CuAAC": {
    "zh": "铜催化叠氮-炔烃环加成"
  },
  "D-galactosamine": {
    "zh": "D-半乳糖胺"
  },
  "DBCO": {
    "zh": "二苯并环辛炔（DBCO）"
  },
  "DMF": {
    "zh": "DMF备案"
  },
  "DMT-on HPLC purification handle": {
    "zh": "DMT-on HPLC纯化把手"
  },
  "DNase I": {
    "zh": "DNase I"
  },
  "Deep Eutectic Solvent": {
    "zh": "深共熔溶剂"
  },
  "Dibenzocyclooctyne": {
    "zh": "二苯并环辛炔"
  },
  "Dual-Target RNAi Drug": {
    "zh": "双靶点RNAi药物"
  },
  "ECO GMP Manufacturing Center": {
    "zh": "ECO GMP生产中心"
  },
  "ECO Synthesis platform": {
    "zh": "ECO Synthesis平台"
  },
  "ECO ligase": {
    "zh": "ECO连接酶"
  },
  "FDA/CDER": {
    "zh": "FDA/CDER"
  },
  "Factor XI": {
    "zh": "凝血因子XI"
  },
  "Fall Line Endurance Fund": {
    "zh": "Fall Line Endurance Fund"
  },
  "Full-Length Product": {
    "zh": "全长产物"
  },
  "G5 GalNAc support": {
    "zh": "G5 GalNAc载体"
  },
  "G5 ribofuranose": {
    "zh": "G5核糖呋喃糖"
  },
  "GDOC": {
    "zh": "GDOC平台"
  },
  "GDOC platform": {
    "zh": "GDOC平台"
  },
  "GEMINI™": {
    "zh": "GEMINI™平台"
  },
  "GMP-grade QC enzyme panel": {
    "zh": "GMP级质控酶组合"
  },
  "GT-multi-siRNA": {
    "zh": "GT-multi-siRNA"
  },
  "GalAhead": {
    "zh": "GalAhead™"
  },
  "GalNAc-PA": {
    "zh": "GalNAc-亚磷酰胺（GalNAc-PA）"
  },
  "GalNAc-siRNA": {
    "zh": "GalNAc-siRNA"
  },
  "GalT": {
    "zh": "GalT"
  },
  "GnTI": {
    "zh": "GnTI"
  },
  "GreenLight Biosciences": {
    "zh": "GreenLight Biosciences"
  },
  "H1 subunit": {
    "zh": "H1亚基"
  },
  "H2 subunit": {
    "zh": "H2亚基"
  },
  "Hongene": {
    "zh": "兆维"
  },
  "Host-Cell Protein": {
    "zh": "宿主细胞蛋白"
  },
  "Huntingtin": {
    "zh": "亨廷顿蛋白"
  },
  "Hydroxyprolinol scaffold": {
    "zh": "羟脯氨醇（tHP）骨架"
  },
  "ICH Q11 Q&A": {
    "zh": "ICH Q11问答"
  },
  "ICH Q13": {
    "zh": "ICH Q13"
  },
  "ICH Q2(R1)": {
    "zh": "ICH Q2(R1)"
  },
  "ICH Q3D(R2)": {
    "zh": "ICH Q3D(R2)"
  },
  "ICP-MS": {
    "zh": "ICP-MS"
  },
  "IND-to-dosing gap": {
    "zh": "IND获批与首次给药时间差"
  },
  "IVT": {
    "zh": "体外转录"
  },
  "Just Climate": {
    "zh": "Just Climate"
  },
  "Kd": {
    "zh": "Kd值"
  },
  "Kinovate Life Sciences": {
    "zh": "Kinovate Life Sciences"
  },
  "L96 ligand": {
    "zh": "L96配体"
  },
  "LDL-C": {
    "zh": "LDL-C"
  },
  "LGC Biosearch Technologies": {
    "zh": "LGC Biosearch Technologies"
  },
  "Leloir glycosyltransferases": {
    "zh": "Leloir糖基转移酶"
  },
  "Locked Nucleic Acid": {
    "zh": "锁核酸"
  },
  "Lp(a)": {
    "zh": "Lp(a)"
  },
  "ManII": {
    "zh": "ManII"
  },
  "Maywavee": {
    "confidence": "high",
    "en_full": "Mabwell",
    "issue": "term 'Maywavee' 为拼写错误，正确英文名为 'Mabwell'，中文规范译名为 '迈威生物'。搜索结果中多条权威医药媒体（新药情报库、医药魔方）均确认 Mabwell → 迈威生物的对应关系。",
    "sources": [
      "https://synapse.zhihuiya.com/blog/%E8%BF%88%E5%A8%81%E7%94%9F%E7%89%A910%E4%BA%BF%E7%BE%8Eyuan%E5%8F%8C%E9%9D%B6sirna%E8%8D%AF%E7%89%A9newco%E5%85%A8%E7%90%83%E6%88%98%E7%95%A5%E8%B5%B7%E8%88%AA",
      "https://synapse.zhihuiya.com/blog/%E8%BF%88%E5%A8%81%E7%94%9F%E7%89%A910%E4%BA%BF%E7%BE%8Eyuan%E5%8F%8C%E9%9D%B6%E7%82%B9sirna%E6%96%B0%E8%8D%AF%E6%88%90%E5%8A%9F%E7%AD%BE%E7%BD%B2newco%E4%BA%A4%E6%98%93",
      "https://bydrug.pharmcube.com/news/detail/06fbf6f2e1174c99eb5f99dc8cceaef8"
    ],
    "verified_at": "2026-04-22",
    "zh": "迈威生物"
  },
  "MutS Homolog 3": {
    "zh": "MutS同源物3"
  },
  "N-acetylgalactosamine": {
    "zh": "N-乙酰半乳糖胺"
  },
  "NAG37": {
    "zh": "NAG37"
  },
  "NDA": {
    "zh": "新药申请"
  },
  "NMPA": {
    "zh": "国家药品监督管理局"
  },
  "Nitto Denko Avecia": {
    "zh": "Nitto Denko Avecia"
  },
  "NittoPhase HL": {
    "zh": "NittoPhase HL"
  },
  "Norroa": {
    "zh": "Norroa"
  },
  "Notice No. 21 of 2026": {
    "zh": "2026年第21号通告"
  },
  "Nuclease P1": {
    "zh": "核酸酶P1"
  },
  "Nucleoside Triphosphate": {
    "zh": "核苷三磷酸"
  },
  "OPR&D": {
    "zh": "《有机工艺研究与开发》（OPR&D）"
  },
  "PCSK9": {
    "zh": "PCSK9"
  },
  "PDE": {
    "zh": "允许日暴露量"
  },
  "PMO synthesis": {
    "zh": "PMO合成"
  },
  "PVA entrapment": {
    "zh": "PVA包埋"
  },
  "Phosphodiester linker": {
    "zh": "磷酸二酯接头"
  },
  "Polynucleotide Kinase (T4)": {
    "zh": "多核苷酸激酶（T4）"
  },
  "Poresyn Solutions": {
    "zh": "Poresyn Solutions"
  },
  "Prime Synthesis CPG": {
    "zh": "Prime Synthesis CPG"
  },
  "PrimeMax siRNA CPG": {
    "zh": "PrimeMax siRNA CPG"
  },
  "Process Analytical Technology": {
    "zh": "过程分析技术"
  },
  "Process Atlas": {
    "zh": "工艺图谱"
  },
  "Process Mass Intensity": {
    "zh": "工艺质量强度"
  },
  "Q3M": {
    "zh": "Q3M"
  },
  "Q6M": {
    "zh": "Q6M"
  },
  "QC biocatalyst": {
    "zh": "质控生物催化剂"
  },
  "RADS™": {
    "zh": "RADS™"
  },
  "RNA interference": {
    "confidence": "high",
    "en_full": "RNA interference",
    "issue": "",
    "sources": [
      "https://www.ronatherapeutics.com/cn/news/45",
      "https://www.zhihuiya.com/news/info_12579.html",
      "https://www.delveinsight.com/report-store/rna-interference-therapy-competitive-landscape"
    ],
    "verified_at": "2026-04-22",
    "zh": "RNA干扰"
  },
  "RNA-Induced Silencing Complex": {
    "zh": "RNA诱导沉默复合体"
  },
  "RNase A": {
    "zh": "核糖核酸酶A"
  },
  "RNase H": {
    "zh": "核糖核酸酶H"
  },
  "RNase Inhibitor": {
    "zh": "RNase Inhibitor"
  },
  "RNase T1": {
    "zh": "核糖核酸酶T1"
  },
  "RSC 2.0 modification": {
    "zh": "RSC 2.0修饰"
  },
  "RiboGalSTAR™": {
    "zh": "RiboGalSTAR™"
  },
  "Ribonuclease T1": {
    "zh": "核糖核酸酶T1"
  },
  "Roche Custom Biotech": {
    "zh": "罗氏定制生物技术"
  },
  "SBIA": {
    "zh": "SBIA"
  },
  "SBS": {
    "zh": "SBS"
  },
  "SMART Digest RNase T1 kit": {
    "zh": "SMART Digest RNase T1试剂盒"
  },
  "SPOS": {
    "zh": "固相合成（SPOS）"
  },
  "ST Pharm": {
    "zh": "ST Pharm"
  },
  "STP122G": {
    "zh": "STP122G"
  },
  "SUGAR-TARGET glycosyl-transferase cascade": {
    "zh": "SUGAR-TARGET糖基转移酶级联反应"
  },
  "Sangon Biotech": {
    "zh": "生工"
  },
  "SiaT": {
    "zh": "SiaT"
  },
  "Snake Venom Phosphodiesterase": {
    "zh": "蛇毒磷酸二酯酶"
  },
  "Sollbruchstellen": {
    "zh": "易断位点"
  },
  "SpyCatcher/SpyTag": {
    "zh": "SpyCatcher/SpyTag"
  },
  "Strain-Promoted Azide–Alkyne Cycloaddition": {
    "zh": "应变促进叠氮–炔烃环加成"
  },
  "Supply-Chain Opportunity Map": {
    "zh": "供应链机会地图"
  },
  "Suzhou Taike": {
    "zh": "苏州泰科"
  },
  "Synthesis Modality": {
    "zh": "合成模式"
  },
  "T4 RNA Ligase 1": {
    "zh": "T4 RNA连接酶1"
  },
  "T4 RNA Ligase 2": {
    "zh": "T4 RNA连接酶2"
  },
  "T7 RNA polymerase": {
    "zh": "T7 RNA聚合酶"
  },
  "TRL": {
    "zh": "技术成熟度"
  },
  "TRiM™": {
    "zh": "TRiM™平台"
  },
  "Takara Bio": {
    "zh": "宝生物工程"
  },
  "Technical Guidelines for Pharmaceutical Research on Chemically Synthesized Oligonucleotide Drugs (Innovative Drugs)": {
    "zh": "化学合成寡核苷酸药物（创新药）药学研究技术指导原则（试行）"
  },
  "Terminal Deoxynucleotidyl Transferase": {
    "zh": "末端脱氧核苷酸转移酶"
  },
  "Tianjin Orilife": {
    "zh": "天津奥利法"
  },
  "Tier 1": {
    "zh": "第一层级"
  },
  "Tier 2": {
    "zh": "第二层级"
  },
  "Tier 3": {
    "zh": "第三层级"
  },
  "Triazole linker": {
    "zh": "三唑接头"
  },
  "TrisGal-6 scaffold": {
    "zh": "TrisGal-6骨架"
  },
  "UDP-Gal": {
    "zh": "UDP-Gal"
  },
  "UDP-GalNAc": {
    "zh": "UDP-GalNAc"
  },
  "Unylinker-functionalized polystyrene support": {
    "zh": "Unylinker功能化聚苯乙烯载体"
  },
  "Vazyme": {
    "zh": "诺唯赞"
  },
  "Worthington Biochemical": {
    "zh": "Worthington Biochemical"
  },
  "WuXi AppTec": {
    "zh": "药明康德"
  },
  "Wuhu Huaren": {
    "zh": "芜湖华仁"
  },
  "XBP-1": {
    "zh": "XBP-1"
  },
  "Yeasen Biotech": {
    "zh": "翌圣生物科技"
  },
  "acceptable daily intake": {
    "zh": "每日可接受摄入量"
  },
  "activated-intermediate shelf life": {
    "zh": "活化中间体货架期"
  },
  "anion-exchange polishing": {
    "zh": "阴离子交换精制"
  },
  "antisolvent": {
    "zh": "反溶剂"
  },
  "arm-coupling reaction": {
    "zh": "臂偶联反应"
  },
  "atom-economy penalty": {
    "zh": "原子经济性损失"
  },
  "avidity plateau": {
    "zh": "亲合力平台"
  },
  "bead attrition": {
    "zh": "微珠磨损"
  },
  "bottom-up mapping": {
    "zh": "自下而上图谱分析"
  },
  "branching-point coupling": {
    "zh": "分支点偶联"
  },
  "bundled enzyme-carrier product": {
    "zh": "酶-载体捆绑产品"
  },
  "cardiometabolic disease": {
    "zh": "心脏代谢疾病"
  },
  "cell-free synthesis": {
    "zh": "无细胞合成"
  },
  "channeling": {
    "zh": "沟流"
  },
  "charge-state deconvolution": {
    "zh": "电荷态反卷积"
  },
  "chemoenzymatic": {
    "zh": "化学酶法"
  },
  "choline chloride/glycerol": {
    "zh": "氯化胆碱/甘油"
  },
  "choline chloride/urea (reline)": {
    "zh": "氯化胆碱/尿素（reline）"
  },
  "class extension": {
    "zh": "品类延伸"
  },
  "clinical translation": {
    "zh": "临床转化"
  },
  "cluster-arm variants": {
    "zh": "簇臂变体"
  },
  "co-dosing program": {
    "zh": "联合给药项目"
  },
  "cocktail formulation": {
    "zh": "鸡尾酒制剂"
  },
  "complement dysregulation": {
    "zh": "补体失调"
  },
  "continuous process verification": {
    "zh": "连续工艺验证"
  },
  "continuous-flow microgel reactor": {
    "zh": "连续流微凝胶反应器"
  },
  "control threshold": {
    "zh": "控制阈值"
  },
  "convergent assembly": {
    "zh": "汇聚式组装"
  },
  "copper scavenging": {
    "zh": "铜清除"
  },
  "copper-residue burden": {
    "zh": "铜残留合规负担"
  },
  "coronary heart disease": {
    "zh": "冠心病"
  },
  "covalently-linked tandem siRNA": {
    "zh": "共价连接串联siRNA"
  },
  "cross-activity": {
    "zh": "交叉活性"
  },
  "denaturing IP-RP-LC-MS": {
    "zh": "变性离子对反相液相色谱-质谱"
  },
  "dendritic scaffold": {
    "zh": "树枝状骨架"
  },
  "design paradigm": {
    "zh": "设计范式"
  },
  "di-valent branched construct": {
    "zh": "二价分支构建体"
  },
  "diamine scaffold": {
    "zh": "二胺骨架"
  },
  "disulfide bond": {
    "zh": "二硫键"
  },
  "domestic-substitution feasibility": {
    "zh": "国产替代可行性"
  },
  "droplet microfluidics": {
    "zh": "液滴微流控技术"
  },
  "dsRNA": {
    "zh": "dsRNA"
  },
  "dual-functional RNAi therapeutic": {
    "zh": "双功能RNAi治疗药物"
  },
  "enantiomeric excess": {
    "zh": "对映体过量值"
  },
  "enzymatic-ligation": {
    "zh": "酶连接"
  },
  "enzyme loading per gram": {
    "zh": "每克载体酶载量"
  },
  "fixed-bed copper-scavenging resin": {
    "zh": "固定床铜清除树脂"
  },
  "glutaraldehyde": {
    "zh": "戊二醛"
  },
  "glycosyl-transferase": {
    "zh": "糖基转移酶"
  },
  "hepatic parenchymal clearance": {
    "zh": "肝实质清除率"
  },
  "hetero-duplex": {
    "zh": "异源双链体"
  },
  "hexaethyleneglycol": {
    "zh": "六乙二醇"
  },
  "hexavalent GalNAc cluster": {
    "zh": "六价GalNAc簇"
  },
  "high-load polymeric support": {
    "zh": "高载量聚合物载体"
  },
  "homo-duplex": {
    "zh": "同源双链体"
  },
  "hypertriglyceridemia": {
    "zh": "高甘油三酯血症"
  },
  "immobilized enzyme": {
    "zh": "固定化酶"
  },
  "immobilized polymerase/phosphatase reactor": {
    "zh": "固定化聚合酶/磷酸酶反应器"
  },
  "inline conversion monitoring": {
    "zh": "在线转化率监测"
  },
  "inter-lot specific activity variation": {
    "zh": "批间比活力变异"
  },
  "junction-verification assay": {
    "zh": "连接位点验证检测"
  },
  "lenticular beads": {
    "zh": "扁豆形微珠"
  },
  "lipid nanoparticle": {
    "zh": "脂质纳米颗粒"
  },
  "liquid-phase oligonucleotide synthesis": {
    "zh": "液相寡核苷酸合成"
  },
  "liquid-phase synthesis": {
    "zh": "液相合成"
  },
  "mRNAi GOLD™": {
    "zh": "mRNAi GOLD™"
  },
  "maleimide-activated agarose": {
    "zh": "马来酰亚胺活化琼脂糖"
  },
  "manufacturing stack": {
    "zh": "制造体系"
  },
  "material diversion strategy": {
    "zh": "物料转移策略"
  },
  "membrane bioreactor": {
    "zh": "膜生物反应器"
  },
  "methacrylate copolymer beads": {
    "zh": "甲基丙烯酸酯共聚物微珠"
  },
  "mixed hyperlipidemia": {
    "zh": "混合型高脂血症"
  },
  "monoantennary GalNAc": {
    "zh": "单天线GalNAc"
  },
  "monomer diversity index": {
    "zh": "单体多样性指标"
  },
  "muRNA": {
    "zh": "muRNA"
  },
  "multivalent GalNAc cluster": {
    "zh": "多价GalNAc簇"
  },
  "multivalent GalNAc scaffold": {
    "zh": "多价GalNAc骨架"
  },
  "murine TdT": {
    "zh": "鼠源TdT"
  },
  "mxRNA": {
    "zh": "mxRNA"
  },
  "neurodegeneration": {
    "zh": "神经退行性疾病"
  },
  "nonclinical guidance": {
    "zh": "非临床指南"
  },
  "nuclease mapping": {
    "zh": "核酸酶图谱分析"
  },
  "packed-bed reactor": {
    "zh": "填充床反应器"
  },
  "partially conjugated strand": {
    "zh": "部分偶联链"
  },
  "particle-integrity monitoring": {
    "zh": "颗粒完整性监测"
  },
  "pentavalent GalNAc": {
    "zh": "五价GalNAc"
  },
  "phosphoramidite monomer": {
    "confidence": "high",
    "en_full": "phosphoramidite monomer",
    "issue": "",
    "sources": [
      "https://broadpharm.com/blog/Modified-Phosphoramidites-in-RNAi-Research",
      "https://www.ractigen.com/sirna-aco-is-a-convenient-phosphoramidite-based-conjugate-that-enables-rnai-in-the-cns-via-local-administration-with-superior-efficacy-in-the-treatment-of-als-rodent-models-poster/",
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC11472056/"
    ],
    "verified_at": "2026-04-22",
    "zh": "亚磷酰胺单体"
  },
  "pipeline inflation": {
    "zh": "管线虚胖"
  },
  "platform-multiplication event": {
    "zh": "平台倍增事件"
  },
  "polymer microgels": {
    "zh": "聚合物微凝胶"
  },
  "pre-validated package": {
    "zh": "预验证文件包"
  },
  "pressure-drop effects": {
    "zh": "压降效应"
  },
  "process debt": {
    "zh": "工艺债务"
  },
  "process node": {
    "zh": "工艺节点"
  },
  "process signature": {
    "zh": "工艺特征"
  },
  "product-specific guidance": {
    "zh": "产品专项指南"
  },
  "protecting-group strategy": {
    "zh": "保护基策略"
  },
  "protective allele": {
    "zh": "保护性等位基因"
  },
  "pyranose": {
    "zh": "吡喃糖"
  },
  "qualification barrier": {
    "zh": "资质壁垒"
  },
  "rSAP": {
    "zh": "rSAP"
  },
  "ratio QC": {
    "zh": "比例质控"
  },
  "receptor-mediated uptake": {
    "zh": "受体内吞"
  },
  "regulatory vector": {
    "zh": "监管向量"
  },
  "release-profile QC": {
    "zh": "释放谱质控"
  },
  "residual enzyme surveillance": {
    "zh": "残留酶监控"
  },
  "ribofuranose scaffold": {
    "zh": "核糖呋喃糖骨架"
  },
  "serially assembled trivalent construct": {
    "zh": "序贯组装三价构建体"
  },
  "siRELIS facility": {
    "zh": "siRELIS工厂"
  },
  "silica bead fines": {
    "zh": "硅胶微珠细粉"
  },
  "solid-phase phosphoramidite synthesis": {
    "zh": "固相亚磷酰胺合成"
  },
  "solid-phase synthesis": {
    "zh": "固相合成"
  },
  "soluble anchor": {
    "zh": "可溶性锚定基团"
  },
  "spacer accessibility": {
    "zh": "间隔臂可及性"
  },
  "splint removal": {
    "zh": "DNA夹板去除"
  },
  "streptavidin-coated silica beads": {
    "zh": "链霉亲和素包被硅胶微珠"
  },
  "structure-activity study": {
    "zh": "构效关系研究"
  },
  "sub-saturation binding regime": {
    "zh": "未饱和结合区间"
  },
  "supplier concentration": {
    "zh": "供应商集中度"
  },
  "swelling index": {
    "zh": "溶胀指数"
  },
  "tetraantennary": {
    "zh": "四天线"
  },
  "tetraloop": {
    "zh": "四环体"
  },
  "top-down intact-mass sequencing": {
    "zh": "自上而下完整质量测序"
  },
  "toxicokinetic subfactor justification": {
    "zh": "毒代动力学亚因子论证"
  },
  "triantennary GalNAc": {
    "zh": "三天线GalNAc"
  },
  "truncated cluster impurity": {
    "zh": "截短型簇杂质"
  }
}